L. rhamnosus HA-114 is an innovative patent-pending probiotic strain able to improve eating and mood-related behaviors in overweight adults undergoing a diet-induced weight loss. It could favor wellness and facilitate adherence during a diet-based weight reduction program, through its action on the brain-gut axis.
Clinical indications/Functionality: Supports weight management efforts during a diet (eating and stress-related behaviors, metabolic health).
Daily dosage in clinical study: 10B CFU
Scientific support: Choi, B., et al. (2021). L. rhamnosus HA-114 improves eating and mood-related behaviors in adults with overweight during weight loss. Submitted
